Skip to content

Launch price: from €29.90 per box. Free delivery from 2 boxes.

disease-modifying treatment for multiple sclerosis

Cladribine

Treats multiple sclerosis. This molecule appears in 87 of the medicines we have indexed.

Our answerNothing to add

Do you need a supplement? No.

No supplement is warranted with this treatment. A varied diet remains the foundation.

Do you also take another treatment?

By the Layer Nutrition editorial teamHow the atlas classifies the 664 molecules

Class
disease-modifying treatment for multiple sclerosis
Indexed medicines
87
Our answer
Nothing to add
Updated
October 2026
01The medication

What this medicine is for

This molecule belongs to the “disease-modifying treatment for multiple sclerosis” category. This disease-modifying treatment modulates the immune system to space out multiple sclerosis relapses.

In practice: Treats multiple sclerosis. It is most often a long-term treatment, taken at regular times over long periods; its benefit is judged over time, not by how you feel on a given day.

The name on your box may be here.

These names come from the public registers of 32 countries: the ANSM for France, the AEMPS for Spain, the AIFA for Italy, the HPRA for Ireland, Swissmedic for Switzerland, and the European Medicines Agency for the others.

Most widespread

  • LEUSTATINE
  • LEUJECT
  • LEUSTATIN
  • ЛЕУДЖЕКТ
  • BIODRIBIN
  • LEUSTAT
  • LITAK
  • MAVENCLAD
See all names, country by countryHide the list by country

France3

  • LEUSTATINE
  • LITAK
  • MAVENCLAD

Germany3

  • LEUSTATIN
  • LITAK
  • MAVENCLAD

Spain3

  • LEUSTATIN
  • LITAK
  • MAVENCLAD

Italy3

  • LEUSTATIN
  • LITAK
  • MAVENCLAD

United Kingdom3

  • LEUSTAT
  • LEUSTAT SUBCUTANEOUS
  • CLADRIBINE ZENTIVA

Ireland2

  • LITAK
  • MAVENCLAD

Switzerland2

  • LITAK
  • MAVENCLAD

Austria3

  • LEUJECT
  • LITAK
  • MAVENCLAD

Belgium3

  • LEUSTATIN
  • LITAK
  • MAVENCLAD

Bulgaria3

  • ЛЕУДЖЕКТ
  • LITAK
  • MAVENCLAD

Cyprus2

  • LITAK
  • MAVENCLAD

Croatia3

  • LEUJECT
  • LITAK
  • MAVENCLAD

Denmark2

  • LITAK
  • MAVENCLAD

Estonia2

  • LITAK
  • MAVENCLAD

Finland3

  • LEUJECT
  • LITAK
  • MAVENCLAD

Greece3

  • LEUSTATIN
  • LITAK
  • MAVENCLAD

Hungary3

  • LEUJECT
  • LITAK
  • MAVENCLAD

Iceland2

  • MAVENCLAD
  • LITAK

Latvia2

  • LITAK
  • MAVENCLAD

Liechtenstein2

  • MAVENCLAD
  • LITAK

Lithuania2

  • LITAK
  • MAVENCLAD

Luxembourg3

  • LEUSTATIN
  • LITAK
  • MAVENCLAD

Malta2

  • LITAK
  • MAVENCLAD

Norway3

  • LEUJECT
  • MAVENCLAD
  • LITAK

Netherlands3

  • LEUSTATIN
  • LITAK
  • MAVENCLAD

Poland4

  • BIODRIBIN
  • LEUJECT
  • LITAK
  • MAVENCLAD

Portugal4

  • LEUSTATIN
  • LITAK
  • MAVENCLAD
  • CLADRIBINA GENERIS

Romania3

  • LEUJECT
  • LITAK
  • MAVENCLAD

Slovakia2

  • LITAK
  • MAVENCLAD

Slovenia3

  • LEUJECT
  • LITAK
  • MAVENCLAD

Sweden3

  • LEUJECT
  • LITAK
  • MAVENCLAD

Czechia3

  • LEUJECT
  • LITAK
  • MAVENCLAD
02Its place in the atlas

One answer out of three.

The atlas gives each molecule one of these three answers. Most call for nothing.

  • Our formula31 molecules
  • An active ingredient to consider59 molecules
  • Nothing to add574 moleculesincluding this one
Fig. 1The outlined square: Cladribine, one molecule among the 664 in the atlas. List: ANSM. Classification: Layer Nutrition.
04Another treatment

Do you also take another treatment?

Type the name written on the box. The atlas gives you its answer.

For example Panadol, Doliprane or paracetamol.